FindTrial
Sign In

Study of treatment with UDCA vs UDCA & Phototherapy in patients of jaundice of Pregnancy

A Comparative Study Of Selected Outcomes Of Treatment With Ursodeoxycolic Acid (UDCA) Vs UDCA+ Phototherapy In Patients With Intrahepatic Cholestasisof Pregnancy - Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032988
Enrollment
40
Registered
2021-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium

Interventions

Intervention1: UDCA: Group 1 will receive UDCA 10-15 mg per kg per day, daily BD or TDS till 37 weeks period of gestation Control Intervention1: UDCA and Phototherapy: Group 2 will receive UDCA 10-15

Sponsors

Armef Forces Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ANC cases with IHCP

Exclusion criteria

Exclusion criteria: Women with pruritic skin diseases and other liver pathologies wh are already on treatment for IHCP Lethal fetal anomalies

Design outcomes

Primary

MeasureTime frame
additional benefit of Phototherapy in treatment of IHCPTimepoint: at baseline and weekly till delivery—

Secondary

MeasureTime frame
5D Pruritus Scale for assessment of Pruritus Lab Parameters ALT and AST Serum Alkaline Phosphatase Gamma Glutamyl Transferase Serum Bilirubin Timepoint: 1 yr—

Countries

India

Contacts

Public ContactApphia Saphir Kathi

Armed Forces Medical College

ajaidoc@gmail.com8075766341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026